Log in to save to my catalogue

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immun...

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d658f5bfe1141c4acf2fa4bf72300b6

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

About this item

Full title

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-11, Vol.12 (1), p.6871-6871, Article 6871

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Several effective SARS-CoV-2 vaccines are currently in use, but effective boosters are needed to maintain or increase immunity due to waning responses and the emergence of novel variants. Here we report that intranasal vaccinations with adenovirus 5 and 19a vectored vaccines following a systemic plasmid DNA or mRNA priming result in systemic and mu...

Alternative Titles

Full title

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2d658f5bfe1141c4acf2fa4bf72300b6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d658f5bfe1141c4acf2fa4bf72300b6

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-27063-4

How to access this item